Medicine: i.v. contrast media in kidney disease

Podcast
News from the World of Medicine
  • Medicine, 2022 12, i.v. contrast media in kidney disease
    29:25
audio
29:25 Min.
Medicine: Mediterranean diet
audio
29:25 Min.
Medicine: Corticosteroids for asthma
audio
29:25 Min.
Medicine: Away from aspirin?
audio
29:25 Min.
Medicine: Mild hypertension during pregnancy
audio
29:25 Min.
Medicine: CT coronary angiography
audio
29:25 Min.
Medicine: Vitamin D supplements do not work
audio
29:25 Min.
Medicine: Covid-19 in the year 2022
audio
29:25 Min.
Medicine: Treatment of outpatients with Covid-19
audio
29:25 Min.
Medicine: Use of platelet-rich plasma

Iodine-based contrast media are injected into a vein (injected intravenously, injected i.v.) and are used to enhance x-rays and CTs. CT: Computed tomography. Gadolinium-based contrast media are injected into a vein (injected intravenously, injected i.v.) and are used to enhance MRIs. MRI: Magnetic resonance imaging.
However, can patients with kidney disease also receive i.v. contrast media? In patients with kidney disease, risks associated with i.v. contrast media are not as high as commonly perceived. This is the result of a recent clinical study and two evidence-based consensus statements. The clinical study was a cohort study that included 156 028 individuals who had a CT pulmonary angiogram with i.v. contrast media. Both consensus statements were carefully done as far as I see, and are evidence-based.
The use of i.v. contrast media usually will result in higher quality x-rays, CTs, and MRIs. Not using i.v. contrast media, when a compelling clinical indication exists to do so, even in patients with kidney disease, risks either misdiagnosis or delayed diagnosis.

Dokumente

2022 12, Medicine, Text, i.v. contrast media in kidney disease, PDF, 146.5 kB Download

Schreibe einen Kommentar